debrisoquin has been researched along with isomethyleugenol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibaldi, M | 1 |
| Bélanger, PM; Hamelin, BA; LeBel, M; Paquet, F; Turgeon, J; Vallée, F | 1 |
| Bechtel, PR; Bechtel, Y; Berard, M; Haffen, E; Masuyer, C; Paintaud, G | 1 |
1 review(s) available for debrisoquin and isomethyleugenol
| Article | Year |
|---|---|
Pharmacogenetics: Part I.
Topics: Acetylation; Cytochrome P-450 Enzyme System; Debrisoquin; Humans; Methylation; Pharmacogenetics; Phenotype; Polymorphism, Genetic | 1992 |
2 other study(ies) available for debrisoquin and isomethyleugenol
| Article | Year |
|---|---|
The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin.
Topics: 1-Naphthylamine; Adolescent; Adrenergic Agents; Adult; Cytochrome P-450 CYP2D6; Debrisoquin; Fluoxetine; Humans; Male; Methylation; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
On the assessment of drug metabolism by assays of codeine and its main metabolites.
Topics: Adult; Chromatography, High Pressure Liquid; Codeine; Cytochrome P-450 CYP2D6; Debrisoquin; Dextromethorphan; Female; Glucuronides; Humans; Linear Models; Male; Methylation; Middle Aged; Morphine; Phenotype; Polymorphism, Genetic; Reproducibility of Results; Sensitivity and Specificity | 2000 |